These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 23244322)
1. A monoclonal antibody specific to glucosyltransferase B of Streptococcus mutans GS-5 and its glucosyltransferase inhibitory efficiency. Kim MA; Lee MJ; Jeong HK; Song HJ; Jeon HJ; Lee KY; Kim JG Hybridoma (Larchmt); 2012 Dec; 31(6):430-5. PubMed ID: 23244322 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies specific to Streptococcus mutans GS-5 glucosyltransferase-C inhibit bacterial glucosyltransferase. Kim MA; Lee KY; Kim JG Monoclon Antib Immunodiagn Immunother; 2013 Oct; 32(5):330-5. PubMed ID: 24111864 [TBL] [Abstract][Full Text] [Related]
3. Development of a monoclonal antibody against glucosyltransferase D of Streptococcus mutans GS 5. Kim MA; Yang YM; So YR; Ko YH; Lim SM; Lee KY; Kim JG Hybridoma (Larchmt); 2011 Aug; 30(4):375-80. PubMed ID: 21851238 [TBL] [Abstract][Full Text] [Related]
4. Protective immunity against Streptococcus mutans infection in mice after intranasal immunization with the glucan-binding region of S. mutans glucosyltransferase. Jespersgaard C; Hajishengallis G; Huang Y; Russell MW; Smith DJ; Michalek SM Infect Immun; 1999 Dec; 67(12):6543-9. PubMed ID: 10569773 [TBL] [Abstract][Full Text] [Related]
5. Oral passive immunization against dental caries in rats by use of hen egg yolk antibodies specific for cell-associated glucosyltransferase of Streptococcus mutans. Hamada S; Horikoshi T; Minami T; Kawabata S; Hiraoka J; Fujiwara T; Ooshima T Infect Immun; 1991 Nov; 59(11):4161-7. PubMed ID: 1834573 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and prediction of epitopic region of antigen Ag I/II and glucosyltransferase from Streptococcus mutans. Cao XX; Fan J; Chen J; Li YH; Fan MW J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):416-421. PubMed ID: 27376814 [TBL] [Abstract][Full Text] [Related]
7. Production of functional ScFv inhibiting Streptococcus mutans glucosyltransferase activity from a hybridoma P126. Tagawa H; Hayakawa M; Shibata Y; Fukushima K; Lee MS; Shiroza T; Abiko Y Hybrid Hybridomics; 2004 Oct; 23(5):305-10. PubMed ID: 15672609 [TBL] [Abstract][Full Text] [Related]
8. Functional and immunogenic characterization of two cloned regions of Streptococcus mutans glucosyltransferase I. Jespersgaard C; Hajishengallis G; Greenway TE; Smith DJ; Russell MW; Michalek SM Infect Immun; 1999 Feb; 67(2):810-6. PubMed ID: 9916095 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of three individual glucosyltransferases produced by Streptococcus mutans using monoclonal antibodies. Tomita Y; Zhu X; Ochiai K; Namiki Y; Okada T; Ikemi T; Fukushima K FEMS Microbiol Lett; 1996 Dec; 145(3):427-32. PubMed ID: 8978097 [TBL] [Abstract][Full Text] [Related]
10. Production of monoclonal antibody against a glucosyltransferase of Streptococcus mutans 6715. Furuta T; Nisizawa T; Chiba J; Hamada S Infect Immun; 1983 Aug; 41(2):872-5. PubMed ID: 6223885 [TBL] [Abstract][Full Text] [Related]
11. Immunological characteristics of a synthetic peptide associated with a catalytic domain of mutans streptococcal glucosyltransferase. Smith DJ; Taubman MA; King WF; Eida S; Powell JR; Eastcott J Infect Immun; 1994 Dec; 62(12):5470-6. PubMed ID: 7960128 [TBL] [Abstract][Full Text] [Related]
12. Immunization of rats with synthetic peptide constructs from the glucan-binding or catalytic region of mutans streptococcal glucosyltransferase protects against dental caries. Taubman MA; Holmberg CJ; Smith DJ Infect Immun; 1995 Aug; 63(8):3088-93. PubMed ID: 7622235 [TBL] [Abstract][Full Text] [Related]
13. Antibodies generated against dextransucrase exhibit potential anticariostatic properties in Streptococcus mutans. Rather SA; Sharma SC; Mahmood A Appl Microbiol Biotechnol; 2020 Feb; 104(4):1761-1772. PubMed ID: 31900558 [TBL] [Abstract][Full Text] [Related]
14. Roles of membrane vesicles from Streptococcus mutans for the induction of antibodies to glucosyltransferase in mucosal immunity. Nakamura T; Iwabuchi Y; Hirayama S; Narisawa N; Takenaga F; Nakao R; Senpuku H Microb Pathog; 2020 Dec; 149():104260. PubMed ID: 32554054 [TBL] [Abstract][Full Text] [Related]
15. Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection. Zhang P; Jespersgaard C; Lamberty-Mallory L; Katz J; Huang Y; Hajishengallis G; Michalek SM Infect Immun; 2002 Dec; 70(12):6779-87. PubMed ID: 12438353 [TBL] [Abstract][Full Text] [Related]
16. Self-assembling anticaries mucosal vaccine containing ferritin cage nanostructure and glucan-binding region of S. mutans glucosyltransferase effectively prevents caries formation in rodents. Cao XX; Li YH; Ye QL; Hu X; Wang TF; Fan MW Hum Vaccin Immunother; 2017 Oct; 13(10):2332-2340. PubMed ID: 28759297 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Streptococcus mutans glucosyltransferase activity by antiserum to a subsequence peptide. Dertzbaugh MT; Macrina FL Infect Immun; 1990 Jun; 58(6):1509-13. PubMed ID: 2140339 [TBL] [Abstract][Full Text] [Related]
18. Novel epitopic region of glucosyltransferase B from Streptococcus mutans. Hoshino T; Kondo Y; Saito K; Terao Y; Okahashi N; Kawabata S; Fujiwara T Clin Vaccine Immunol; 2011 Sep; 18(9):1552-61. PubMed ID: 21795464 [TBL] [Abstract][Full Text] [Related]
19. A feasible enzyme-linked immunosorbent assay system using monoclonal and polyclonal antibodies against glucosyltransferase-B from Streptococcus mutans. Shinozaki-Kuwahara N; Hashizume-Takizawa T; Hirasawa M; Takada K Hybridoma (Larchmt); 2012 Jun; 31(3):176-9. PubMed ID: 22741581 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of glucosyltransferase activities of Streptococcus mutans by a monoclonal antibody to a subsequence peptide. Chia JS; Lin RH; Lin SW; Chen JY; Yang CS Infect Immun; 1993 Nov; 61(11):4689-95. PubMed ID: 8406867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]